Genmark Diagnostics Inc Quick Ratio (GNMK) starting from the fourth quarter 2020 to fourth quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Genmark Diagnostics Inc   (NASDAQ: GNMK)

Genmark Diagnostics Inc 's Quick Ratio

GNMK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2020, Quick Ratio fell to 3.12 below Genmark Diagnostics Inc average.

Within Medical Equipment & Supplies industry 66 other companies have achieved higher Quick Ratio than Genmark Diagnostics Inc in fourth quarter 2020. While Quick Ratio total ranking in the fourth quarter 2020 has deteriorated compared to the prior quarter from 983 to 1087.

Explain Quick Ratio?
How much Cash & cash equivalents GNMK´s has?
What are GNMK´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GNMK Quick Ratio (Dec 31 2020)
Q4		 (Sep 30 2020)
Q3		 (Jun 30 2020)
Q2		 (Mar 31 2020)
Q1		 (Dec 31 2019)
Q4
Y / Y Current Liabilities Change 82.6 % 91.41 % 152.94 % 122.75 % 69.5 %
Y / Y Cash & cash equivalent Change 139.72 % 313.65 % 221.07 % -2.8 % 18.36 %
Quick Ratio MRQ 3.12 3.62 4.87 1.89 2.38
GNMK's Total Ranking # 1087 # 983 # 803 # 193 # 756
Seq. Current Liabilities Change 8.19 % 39.06 % 9.31 % 11.03 % 13.41 %
Seq. Cash & cash equivalent Change -6.65 % 3.38 % 182.15 % -11.96 % 61.09 %



Quick Ratio fourth quarter 2020 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 67
Healthcare Sector # 502
Overall Market # 1087


Quick Ratio Statistics
High Average Low
13.42 4.58 1.15
(Sep 30 2013)   (Mar 31 2017)




Financial Statements
Genmark Diagnostics Inc 's Current Liabilities $ 41 Millions Visit GNMK's Balance sheet
Genmark Diagnostics Inc 's Cash & cash equivalent $ 128 Millions Visit GNMK's Balance sheet
Source of GNMK's Sales Visit GNMK's Sales by Geography


Cumulative Genmark Diagnostics Inc 's Quick Ratio

GNMK's Quick Ratio for the trailling 12 Months

GNMK Quick Ratio

 (Dec 31 2020)
12 Months		 (Sep 30 2020)
12 Months		 (Jun 30 2020)
12 Months		 (Mar 31 2020)
12 Months		 (Dec 31 2019)
12 Months
Y / Y Current Liabilities TTM Growth 104.11 % 104.56 % 104.75 % 16.88 % -21.62 %
Y / Y Cash & cash equivalent TTM Growth 152.39 % 120.41 % 50.05 % -8.58 % -15.4 %
Quick Ratio TTM 3.39 3.29 2.82 2.24 2.74
Total Ranking TTM # 4481 # 4494 # 243 # 4575 # 402
Seq. Current Liabilities TTM Growth 16.48 % 19.16 % 21.14 % 21.39 % 16.74 %
Seq. Cash & cash equivalent TTM Growth 20.15 % 39.06 % 52.23 % -0.77 % 4.93 %

Quick ratio ranking by company, industry and sector >> Back to GNMK Financial Strength Comparisons >> Go to Compare GNMK Quick Ratio to its Competitors

On the trailing twelve months basis GNMK Cash & cash equivalent more than doubled by 139.72 % in Q4 2020 year on year, faster than Current Liabilities, this led to increase in in Genmark Diagnostics Inc 's Quick Ratio to 3.39, Quick Ratio remained below GNMK average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 192 other companies have achieved higher Quick Ratio than Genmark Diagnostics Inc . While Quick Ratio overall ranking has improved so far to 4481, from total ranking during the twelve months ending third quarter 2020 at 4494.

Explain Quick Ratio?
How much Cash & cash equivalents GNMK´s has?
What are GNMK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 193
Healthcare Sector # 907
Within the Market # 4481


trailing twelve months Quick Ratio Statistics
High Average Low
10.02 4.19 1.89
(June 30. 2014)   (Mar 31 2017)




Companies with similar Quick Ratio in the quarter ending Dec 31 2020, within Medical Equipment & Supplies Industry Quick RatioDec 31 2020 MRQ Cash & cash equivalentDec 31 2020 MRQ Current Liabilities
Outset Medical Inc   8.58 $ 314.870  Millions$ 36.692  Millions
Meihua International Medical Technologies Co Ltd  8.50 $ 37.072  Millions$ 4.360  Millions
Rxsight Inc   8.40 $ 68.975  Millions$ 8.207  Millions
Penumbra Inc  8.37 $ 264.832  Millions$ 31.658  Millions
Nephros Inc   8.31 $ 8.249  Millions$ 0.993  Millions
Shockwave Medical Inc   7.91 $ 202.354  Millions$ 25.581  Millions
Procept Biorobotics Corporation  7.82 $ 100.907  Millions$ 12.896  Millions
Alpha Tau Medical Ltd  7.75 $ 16.174  Millions$ 2.088  Millions
Endra Life Sciences Inc  7.54 $ 7.227  Millions$ 0.959  Millions
Koru Medical Systems Inc   7.45 $ 27.315  Millions$ 3.666  Millions
Orasure Technologies Inc  7.42 $ 305.718  Millions$ 41.208  Millions
Novocure Limited  7.42 $ 842.576  Millions$ 113.612  Millions
Glucotrack Inc   7.30 $ 9.823  Millions$ 1.345  Millions
Cytosorbents Corporation  7.03 $ 71.422  Millions$ 10.153  Millions
Babylon Holdings Limited  6.97 $ 103.579  Millions$ 14.862  Millions
Catheter Precision Inc   6.62 $ 23.906  Millions$ 3.609  Millions
Clearpoint Neuro Inc   6.28 $ 20.099  Millions$ 3.200  Millions
Semler Scientific inc   6.22 $ 22.079  Millions$ 3.551  Millions
Marizyme Inc   6.07 $ 2.903  Millions$ 0.478  Millions
Axonics Inc   5.89 $ 241.181  Millions$ 40.945  Millions
Biolife Solutions Inc   5.81 $ 90.403  Millions$ 15.573  Millions
Renovacare Inc   5.76 $ 7.421  Millions$ 1.289  Millions
Modular Medical Inc  5.66 $ 3.222  Millions$ 0.569  Millions
Tandem Diabetes Care Inc   5.57 $ 484.936  Millions$ 86.985  Millions
Streamex Corp   5.53 $ 28.268  Millions$ 5.108  Millions
Altitude Acquisition Corp   5.46 $ 0.764  Millions$ 0.140  Millions
Vivos Therapeutics Inc   5.35 $ 18.206  Millions$ 3.403  Millions
Acutus Medical Inc   5.18 $ 131.073  Millions$ 25.304  Millions
Irhythm Holdings Inc   5.10 $ 335.217  Millions$ 65.665  Millions
Milestone Scientific Inc   4.94 $ 14.224  Millions$ 2.878  Millions

Date modified: 2026-09-08T15:10:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.